Project Detail
"mTOR expression in breast carcinomas and the ability of everolimus (RAD 001) to modulate its expression"
 
Team
 
Sponsor
Novartis Farma
 
Dates and Lifetime
From: 2009-11-02 To: 2012-11-02
Duration: 36 months
 
Reference
  
Send Email
From
To
Subject